Status:

COMPLETED

An 18-Month Psychotherapy of Borderline Personality Disorder

Lead Sponsor:

Weill Medical College of Cornell University

Conditions:

Borderline Personality Disorder

Eligibility:

FEMALE

18-35 years

Phase:

NA

Brief Summary

The purpose of the study is to examine the impact of an 18-month psychotherapy treatment for borderline personality disorder. The investigators will examine changes in psychosocial and work functionin...

Detailed Description

Patients with borderline personality disorder (BPD) will be provided with an empirically supported form of psychotherapy for BPD patients called transference-focused psychotherapy (TFP) and medication...

Eligibility Criteria

Inclusion

  • We are recruiting female patients between the ages of 18-35 who meet DSM criteria for BPD.

Exclusion

  • We are excluding patients who meet the following criteria:
  • psychotic disorders
  • a current major depressive episode
  • bipolar I disorder
  • current substance dependence
  • antisocial personality disorder.
  • unable to undergo 18-months of twice weekly psychotherapy in NYC

Key Trial Info

Start Date :

January 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 10 2024

Estimated Enrollment :

61 Patients enrolled

Trial Details

Trial ID

NCT03329677

Start Date

January 1 2016

End Date

February 10 2024

Last Update

February 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NewYork-Presbyterian/Weill Cornell Medical Center

New York, New York, United States, 10065